Cardiovascular diseases increase with the age of the individual and as the world's population will have an increasing number of aged members by the year 2000, these diseases deserve special attention. The present state of our knowledge is reviewed, and the author concludes that there is only a single motto for the future: Prevention.
Get full access to this article
View all access options for this article.
References
1.
McHateJ and McHateM. C., Future StudiesiAn International Survey. United Nations Institute for Training and Research,
2.
DubosR., Man adapting, Yale University Press, (1965).
3.
BraunwaldE, Future shock in academic medicine. N. Engl. J. Med. 286, 1031–1035 (1972).
4.
FabregaH.Jr., The need for an ethnomedical science. Science189, 969–975 (1975).
5.
EngelG. L., The need for a new medical model: a challenge for biomedicine. Science196, 129–136 (1977).
6.
AujaleuE., Prospective studies and future action in the public health field. Council of Europe, European Public Health Committee, Strasbourg (1972).
7.
Office of Health Economics, Medicines in the1990s: a technological forecast, Office of Home Economics, London(1969).
8.
SelbyP., Health in 1980–1990. A predictive study based on an international inquiry. S. Karger, (1974).
9.
World Health Organization. Manual of mortality analysis. WHO, Geneva (1977).
10.
United Nations Department of Economic and Social Affairs, The ageing: trends and policies. United Nations, New York (1975).
11.
KleczkowskiB. M., MachE. P. and ThomasR. G., Containing the rising cost of medical care under social security. WHO Chronicle31, 403–412 (1977).
12.
GordonT and ThomT., The recent decrease in CHD mortality. Prev. Med. 4, 115–125 (1975).
13.
WalkerW. J., Changing United States life-style and declining vascular mortality; cause or coincidence?N. Engl. J. Med. 297, 163–165 (1977).
14.
BaumgartnerH, R, der AtheroskleroseZur Pathogenese. Beitrag aus zetlbiologischer Sicht.Schweiz. Med. Wochenschr. 107, 717—722 (1977).
15.
BendittE. P., Evidence for a monoclonal origin of human atherosclerotic plaques and some implications. Circulation50, 650–652 (1974).
16.
NiehausC. E., WoottonR.LewisJ., NicollAi, WilliamsB., ColtartD. J. and LewisB., Influence of lipid concentrations and age on transfer of plasma lipoprotein into human arterial intima.Lancet469–471 (1977).
17.
MarxJ. L., Blood clotting: the role of the prostaglandins. Science196, 1072–1075 (1977).
18.
WisslerR. W. and VesselinovitchD., Regression of atherosclerosis in experimental animals and man. Modern Concepts of Cardiovascular Disease46, 27–32 (1977).
19.
Editorial, Regression of atheroma. Brit. Med. J. 1–2 (1977).
20.
MesarovicM. and PestelE., Mankind at the Turning Point, Hutchinson, London (1975).
21.
LüthP., Aussichten einer künftigen Medizin. Carl Hauser Verlag, Munich (1971).
22.
Bui-Dang-Ha DoanJ., Specialization of physicians: levels and trends in some industrialized countries.World Health Statistics Report30, 207–226 (1977).
23.
PaukerS. G., Surgical therapy for coronary artery disease: caveat emptor. Am. Heart J. 93, 543–546 (1977).
24.
ApsteinC. S., KlineS. A., LevinD. C., BaltaxeH. A. and KillipT., Left ventricular performance and graft patency after coronary artery-saphenous vein bypass surgery: early and late follow-up. Am. Heart J. 93, 547–555 (1977).
25.
HardyJ. T., Science, Technology and the Environment, Saunders, (1975).
26.
HayflickL., The cell biology of human ageing. New Engl. J. Med. 295, 1302–1308 (1976).
